The kinetics of neutrophil activation. The response to chemotactic peptides depends upon whether ligand-receptor interaction is rate-limiting.

This publication has 18 references indexed in Scilit:

• Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
  Journal of Clinical Investigation, 1980
• Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.
  Journal of Clinical Investigation, 1980
• Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.
  Journal of Clinical Investigation, 1980
• Chemotactic peptide receptor modulation in polymorphonuclear leukocytes.
  The Journal of cell biology, 1980
• Further studies on the structural requirements for synthetic peptide chemoattractants
  Biochemistry, 1980
• Use of cytochalasin B to distinguish between early and late events in neutrophil activation
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1980
• Stimulus-response coupling in the human neutrophil Transmembrane potential and the role of extracellular Na+
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1980
• Involvement of membrane calcium in the response of rabbit neutrophils to chemotactic factors as evidenced by the fluorescence of chlorotetracycline.
  The Journal of cell biology, 1979
• Receptor-Mediated Internalization of Fluorescent Chemotactic Peptide by Human Neutrophils
  Science, 1979
• Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.
  Journal of Clinical Investigation, 1975